drug

safusidenib

Phase 3updated 3mo ago

by $NUVB Nuvation Bio Inc.

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying safusidenib

phase2Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Diseasenot yet recruitingn=40
phase3SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)recruitingn=365
EP1A Study of AB-218 in Patients With IDH1 Mutated Low Grade Gliomacompletedn=14

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

safusidenib

Phase 3updated 3mo ago

by $NUVB Nuvation Bio Inc.

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying safusidenib

phase2Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Diseasenot yet recruitingn=40
phase3SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)recruitingn=365
EP1A Study of AB-218 in Patients With IDH1 Mutated Low Grade Gliomacompletedn=14

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

safusidenib

all catalysts(0)

Trials studying safusidenib

News(0)

Report a data issue

comments(0)

safusidenib

all catalysts(0)

Trials studying safusidenib

News(0)

Report a data issue

comments(0)